Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development
-
Published:2022-09-18
Issue:
Volume:
Page:
-
ISSN:1359-4184
-
Container-title:Molecular Psychiatry
-
language:en
-
Short-container-title:Mol Psychiatry
Author:
Kaspi Antony, Hildebrand Michael S.ORCID, Jackson Victoria E.ORCID, Braden Ruth, van Reyk Olivia, Howell Tegan, Debono Simone, Lauretta Mariana, Morison Lottie, Coleman Matthew J., Webster Richard, Coman David, Goel Himanshu, Wallis Mathew, Dabscheck Gabriel, Downie Lilian, Baker Emma K., Parry-Fielder Bronwyn, Ballard Kirrie, Harrold Eva, Ziegenfusz Shaun, Bennett Mark F.ORCID, Robertson Erandee, Wang LongfeiORCID, Boys Amber, Fisher Simon E.ORCID, Amor David J.ORCID, Scheffer Ingrid E.ORCID, Bahlo MelanieORCID, Morgan Angela T.ORCID
Abstract
AbstractChildhood apraxia of speech (CAS), the prototypic severe childhood speech disorder, is characterized by motor programming and planning deficits. Genetic factors make substantive contributions to CAS aetiology, with a monogenic pathogenic variant identified in a third of cases, implicating around 20 single genes to date. Here we aimed to identify molecular causation in 70 unrelated probands ascertained with CAS. We performed trio genome sequencing. Our bioinformatic analysis examined single nucleotide, indel, copy number, structural and short tandem repeat variants. We prioritised appropriate variants arising de novo or inherited that were expected to be damaging based on in silico predictions. We identified high confidence variants in 18/70 (26%) probands, almost doubling the current number of candidate genes for CAS. Three of the 18 variants affected SETBP1, SETD1A and DDX3X, thus confirming their roles in CAS, while the remaining 15 occurred in genes not previously associated with this disorder. Fifteen variants arose de novo and three were inherited. We provide further novel insights into the biology of child speech disorder, highlighting the roles of chromatin organization and gene regulation in CAS, and confirm that genes involved in CAS are co-expressed during brain development. Our findings confirm a diagnostic yield comparable to, or even higher, than other neurodevelopmental disorders with substantial de novo variant burden. Data also support the increasingly recognised overlaps between genes conferring risk for a range of neurodevelopmental disorders. Understanding the aetiological basis of CAS is critical to end the diagnostic odyssey and ensure affected individuals are poised for precision medicine trials.
Funder
Department of Health | National Health and Medical Research Council Department of Health, Australian Government
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference65 articles.
1. American Speech-Language-Hearing A. Childhood apraxia of speech [Technical report]. 2007. 2. Morgan AT, Murray E, Liégeois FJ. Interventions for childhood apraxia of speech. Cochrane Database Syst Rev. 2018;5:CD006278. 3. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001;413:519–23. 4. Eising E, Carrion-Castillo A, Vino A, Strand EA, Jakielski KJ, Scerri TS, et al. A set of regulatory genes co-expressed in embryonic human brain is implicated in disrupted speech development. Mol Psychiatry. 2019;24:1065–78. 5. Hildebrand MS, Jackson VE, Scerri TS, Van Reyk O, Coleman M, Braden RO, et al. Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation. Neurology 2020;94:e2148–e2167.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|